This second edition features the latest information from the Food & Drug Administration's Pharmaceutical CGMP's for the 21st Century Risk Based Approach Final Report along with many other up to date guidance documents. Information from the latest international GMP documents, such as the European GMP Directive, has also been included in this updated edition.

The success of the first edition can be shown through the diversity of its purchasers. Many large pharmaceutical and biotechnology companies in the United States, Europe and the Middle East have purchased the first edition. This training package is not only useful to companies but also many community colleges and universities have purchased the BioGMP™ training package.

We continue to look forward to learning about your experience with the use of BioGMP™ in corporate or college settings; please keep us informed of your progress with this second edition of the training program and watch for future additions to this product.